Uterine Artery Embolization:
A Non-Surgical Approach to Fibroid Tumors


Vol. 10, No. 4
December, 2000

  • Winthrop Ranked #1 in Metropolitan Region for Open-Heart Surgery

  • Telemetry Monitoring Units Safeguard Cardiac Patients

  • Cardiac Rehabilitation Program Certified

  • Uterine Artery Embolization:
    A Non-Surgical Approach to Fibroid Tumors

  • Osteoporosis Studies Recruit Women

  • Senator Balboni Sponsors Grant for Neonatal Transport System

  • Re-Opening of Expanded Pulmonary Rehabilitation Unit

  • Respiratory Syncytial Virus Trials Focus on Children

  • Combating Tickborne Infectious Diseases

  • Warding off the Flu

  • Arabian Nights Gala Benefits Hospital

  • Changes to Winthrop’s Board of Directors

  • New Members Elected to Winthrop’s Board of Directors

  • Winthrop Directors Cut Ribbon at New Hospital Entrance

  • Senior Volunteer Awards Luncheon
    In appreciation of our devoted volunteers

  • New Name For The Long Island Poison Control Center

  • Winthrop Hosts Child Health Plus Open Enrollment

  • VALENTINE’S DAY PARTY FOR KIDS

  • Copyright

    Back to Publications


  • Sidney Glanz, MD, Chief, Interventional Radiology with the Department of Radiology at Winthrop
    Uterine artery embolization is a relatively new procedure used as a non-surgical alternative to treat benign tumors of the uterus, also known as fibroids,” said Sidney Glanz, MD, Chief, Interventional Radiology with the Department of Radiology at Winthrop. Dr. Glanz performs the procedure in the Hospital’s new Interventional Radiology Suite.

    “One of the characteristics of these benign tumors is that they require an abnormally large blood supply,” explained Dr. Glanz. “In this procedure, we significantly reduce the blood supply to the uterus, thereby diminishing blood supply to the tumor.”

    Fibroids can affect women of any age, and result in pain and excessive bleeding. By restricting blood flow to the area, uterine artery embolization shrinks the tumor, which in turn lessens pain and bleeding.

    At Winthrop, the procedure is performed on a one-day hospital stay basis, meaning that women typically remain in the hospital for a total of 23 hours. “This enables us to effectively control pain and discomfort following the procedure,” said Dr. Glanz.

    “As an alternative to hysterectomy or surgical removal of the fibroids, uterine artery embolization appears to be an extremely effective technique,” said Dr. Glanz. “Because our results over the past two years have been so positive, the procedure is now being considered as a possible treatment for women who would like to preserve their fertility.”

    For additional information, call (516) 663-2452.

    Osteoporosis Studies Recruit Women



    The Bone Mineral Research Center at Winthrop announced a new clinical trial of a self-injectable osteoporosis medication. Post-menopausal women, previously diagnosed with osteoporosis, who have suffered a fracture, are urged to participate.

    They must be willing to commit themselves to the protocol time period, during which they will be monitored through bone density testing, physical examinations, and laboratory tests.

    John F. Aloia, MD, Chief Academic Officer at Winthrop, an internationally recognized expert in osteoporosis, is conducting the clinical trials, which are coordinated by Jane Moore, RN, MSN, CCRC, Nurse Specialist.

    Medically appropriate women are invited to call Ms. Moore at (516) 663-2772 for more information.



    [ Home | Search | Contact | Directions | Privacy Notice ]

    Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

    This site provides information as a resource. It is not a substitute for professional medical advice.
    Always consult a physician or healthcare provider for treatment and guidance toward good health.
    Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design